NCP Inc. Purchases 3,055 Shares of Omega Healthcare Investors, Inc. (NYSE:OHI)

NCP Inc. raised its holdings in shares of Omega Healthcare Investors, Inc. (NYSE:OHI) by 55.0% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 8,610 shares of the real estate investment trust’s stock after acquiring an additional 3,055 shares during the quarter. NCP Inc.’s holdings in Omega Healthcare Investors were worth $326,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently made changes to their positions in OHI. Daiwa Securities Group Inc. increased its position in shares of Omega Healthcare Investors by 317.7% during the 3rd quarter. Daiwa Securities Group Inc. now owns 3,949,368 shares of the real estate investment trust’s stock worth $160,739,000 after purchasing an additional 3,003,845 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its stake in Omega Healthcare Investors by 328.6% in the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,661,964 shares of the real estate investment trust’s stock valued at $67,642,000 after acquiring an additional 1,274,238 shares during the last quarter. FMR LLC grew its position in shares of Omega Healthcare Investors by 9.9% in the 3rd quarter. FMR LLC now owns 4,216,835 shares of the real estate investment trust’s stock valued at $171,625,000 after acquiring an additional 380,626 shares during the period. Franklin Resources Inc. increased its stake in shares of Omega Healthcare Investors by 441.4% during the 3rd quarter. Franklin Resources Inc. now owns 429,993 shares of the real estate investment trust’s stock worth $17,177,000 after purchasing an additional 350,570 shares during the last quarter. Finally, Parallax Volatility Advisers L.P. lifted its stake in Omega Healthcare Investors by 115.9% in the 3rd quarter. Parallax Volatility Advisers L.P. now owns 34,982 shares of the real estate investment trust’s stock valued at $1,424,000 after purchasing an additional 254,471 shares during the last quarter. 65.25% of the stock is currently owned by institutional investors and hedge funds.

Omega Healthcare Investors Stock Performance

NYSE:OHI opened at $37.12 on Wednesday. The company has a market cap of $10.46 billion, a price-to-earnings ratio of 23.95, a PEG ratio of 1.09 and a beta of 0.99. Omega Healthcare Investors, Inc. has a fifty-two week low of $29.66 and a fifty-two week high of $44.42. The company has a debt-to-equity ratio of 1.02, a quick ratio of 7.07 and a current ratio of 7.07. The stock has a fifty day moving average price of $37.27 and a 200-day moving average price of $39.05.

Omega Healthcare Investors (NYSE:OHI) last announced its quarterly earnings data on Wednesday, February 5th. The real estate investment trust reported $0.74 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.41 by $0.33. Omega Healthcare Investors had a net margin of 38.65% and a return on equity of 9.71%. As a group, equities analysts anticipate that Omega Healthcare Investors, Inc. will post 2.86 EPS for the current fiscal year.

Omega Healthcare Investors Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, February 18th. Shareholders of record on Monday, February 10th were paid a dividend of $0.67 per share. This represents a $2.68 annualized dividend and a yield of 7.22%. The ex-dividend date of this dividend was Monday, February 10th. Omega Healthcare Investors’s payout ratio is presently 172.90%.

Wall Street Analyst Weigh In

A number of equities analysts have weighed in on the company. Royal Bank of Canada boosted their price target on Omega Healthcare Investors from $39.00 to $43.00 and gave the stock a “sector perform” rating in a research report on Monday, November 11th. BMO Capital Markets upgraded Omega Healthcare Investors from a “market perform” rating to an “outperform” rating and set a $45.00 price target on the stock in a research note on Monday, December 9th. Mizuho upped their price objective on shares of Omega Healthcare Investors from $35.00 to $37.00 and gave the company a “neutral” rating in a report on Thursday, December 5th. JMP Securities reissued a “market perform” rating on shares of Omega Healthcare Investors in a research report on Friday, February 7th. Finally, BNP Paribas upgraded shares of Omega Healthcare Investors from a “neutral” rating to an “outperform” rating and set a $49.00 price target on the stock in a research note on Thursday, October 31st. Five equities research analysts have rated the stock with a hold rating and five have given a buy rating to the stock. Based on data from MarketBeat.com, Omega Healthcare Investors presently has an average rating of “Moderate Buy” and an average price target of $41.67.

Omega Healthcare Investors Profile

Omega Healthcare Investors, Inc engages in the provision of financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities, assisted living facilities, independent living facilities, rehabilitation and acute care facilities, and medical office buildings.